Ledipasvir/sofosbuvir for HCV genotype 1, 2, 4–6 infection: Real-world evidence from a nationwide registry in Taiwan
Journal
Journal of the Formosan Medical Association
Journal Volume
121
Journal Issue
8
Pages
1567-1578
Date Issued
2022
Author(s)
Lo C.-C.
Huang C.-F.
Cheng P.-N.
Tseng K.-C.
Chen C.-Y.
Kuo H.-T.
Huang Y.-H.
Tai C.-M.
Peng C.-Y.
Bair M.-J.
Chen C.-H.
Yeh M.-L.
Lin C.-L.
Lin C.-Y.
Lee P.-L.
Chong L.-W.
Hung C.-H.
Chang T.S.
Huang J.-F.
Yang C.-C.
Hu J.-T.
Lin C.-W.
Chen C.-T.
Wang C.-C.
Su W.-W.
Hsieh T.-Y.
Lin C.-L.
Tsai W.-L.
Lee T.-H.
Chen G.-Y.
Wang S.-J.
Chang C.-C.
Mo L.-R.
Yang S.-S.
Wu W.-C.
Huang C.-S.
Hsiung C.-K.
Kao C.-N.
Tsai P.-C.
Lee M.-H.
Dai C.-Y.
Chuang W.-L.
Lin H.-C.
Yu M.-L.
TACR investigators
Publisher
Elsevier B.V.
Type
journal article